RBR

rocuronium

Find entries where: RBR

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	rocuronium
Identifiers	[(2~{S},3~{S},5~{S},8~{R},9~{S},10~{S},13~{S},14~{S},16~{S},17~{R})-10,13-dimethyl-2-morpholin-4-yl-3-oxidanyl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl] ethanoate
Formula	C₃₂ H₅₃ N₂ O₄
Molecular Weight	529.774
Type	NON-POLYMER
Isomeric SMILES	CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
InChI	InChI=1S/C32H53N2O4/c1-5-14-34(15-6-7-16-34)28-20-26-24-9-8-23-19-29(36)27(33-12-17-37-18-13-33)21-32(23,4)25(24)10-11-31(26,3)30(28)38-22(2)35/h5,23-30,36H,1,6-21H2,2-4H3/q+1/t23-,24+,25-,26-,27-,28-,29-,30-,31-,32-/m0/s1
InChIKey	YXRDKMPIGHSVRX-OOJCLDBCSA-N

Chemical Details
Formal Charge	1
Atom Count	91
Chiral Atom Count	10
Bond Count	96
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB00728
Name	Rocuronium
Groups	approved
Description	Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, rocuronium has rapid onset, and intermediate duration of action. It is commonly marketed under the trade names Zemuron and Esmeron. The drug is associated with the risk of developing allergic reactions in some high-risk patients, such as those with asthma. However, there was a similar incidence of allergic reactions associated with other non-depolarizing neuromuscular blocking agents. [Sugammadex] is a γ-cyclodextrin derivative that has been introduced as a novel agent to reverse the action of rocuronium.
Synonyms	Rocuronium bromide Rocuronio Rocuronium
Brand Names	Zemuron Rocuronium Bromide Injection Sdz Rocuronium Bromide Injectable Rocuronium Bromide Rocuronium bromide Rocuronium Bromide Injection Rocuronium
Indication	For inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Categories	Agents producing tachycardia Androstanes Androstanols Anticholinergic Agents Central Nervous System Depressants Fused-Ring Compounds Muscarinic Antagonists Muscle Relaxants Muscle Relaxants, Peripherally Acting Agents Musculo-Skeletal System Neuromuscular Agents Neuromuscular Blocking Agents Neuromuscular Nondepolarizing Blockade Neuromuscular-Blocking Agents (Nondepolarizing) Nicotinic Antagonists OCT1 inhibitors OCT1 substrates Peripheral Nervous System Agents Steroids
ATC-Code	M03AC09
CAS number	143558-00-3

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Neuronal acetylcholine receptor subunit alpha-2	MGPSCPVFLSFTKLSLWWLLLTPAGGEEAKRPPPRAPGDPLSSPSPTALP...	unknown	antagonist
Muscarinic acetylcholine receptor M2	MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKV...	unknown	antagonist
5-hydroxytryptamine receptor 3A	MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVR...	unknown	antagonist
Solute carrier family 22 member 1	MPTVDDILEQVGESGWFQKQAFLILCLLSAAFAPICVGIVFLGFTPDHHC...	unknown	substrate
Solute carrier organic anion transporter family member 1A2	MGETEKRIETHRIRCLSKLKMFLLAITCAFVSKTLSGSYMNSMLTQIERQ...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682